Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Brain Research. Molecular Brain Research|December 5, 1997
Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapyM Morissette, M Goulet, J J Soghomonian, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
A trial of dextromethorphan in parkinsonian patients with motor response complicationsL Verhagen Metman, P J Blanchet, P van den Munckhof, et al.
Brain Research|May 22, 1995
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complexF Calon, M Goulet, P J Blanchet, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeysP J Blanchet, F Calon, J C Martel, et al.
Clinical Neuropharmacology|December 9, 1998
Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's diseaseP J Blanchet, J Fang, M Gillespie, et al.
Experimental Brain Research|October 25, 2007
Sensorimotor adaptation in Parkinson's disease: evidence for a dopamine dependent remapping disturbanceF Paquet, M A Bedard, M Levesque, et al.
Synapse (New York, N.Y.)|April 17, 2001
Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporterF Calon, N Lavertu, A M Lemieux, et al.
Trends in Neurosciences|October 29, 2000
Dopamine-receptor stimulation: biobehavioral and biochemical consequencesF Calon, A Hadj Tahar, P J Blanchet, et al.
Pageof 4